Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Related studies linked through entity extraction aliases.